Synthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albumin

BMC Structural Biology

Volumn 14, Issue 1, 2014, Pages

  Sivertsen, Annfrid ^a   Isaksson, Johan ^a   Leiros, Hanna Kirsti S ^a   Svenson, Johan ^a   Svendsen, John Sigurd ^a   Brandsdal, Bjørn Olav ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Albumin binding; Crystal structure; Drug site II; Group epitope mapping; Isothermal titration calorimetry; Molecular docking; NMR

Indexed keywords

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BINDING SITES; CALORIMETRY; ESCHERICHIA COLI; HUMANS; HYDROGEN BONDING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR DOCKING SIMULATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; SERUM ALBUMIN; STAPHYLOCOCCUS AUREUS; THERMODYNAMICS;

EID: 84892729193     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-14-4     Document Type: Article

References (48)

1. Molecular aspects of ligand binding to serum albumin. Kragh-Hansen U, Pharmacol Rev 1981 33 1 17 53 7027277
2. Atomic structure and chemistry of human serum albumin. He XM, Carter DC, Nature 1992 358 6383 209 215 10.1038/358209a0 1630489
3. Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. Ryan AJ, Ghuman J, Zunszain PA, Chung C-W, Curry S, J Struct Biol 2011 174 1 84 91 10.1016/j.jsb.2010.10.004 20940056
4. Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin. Hein KL, Kragh-Hansen U, Morth JP, Jeppesen MD, Otzen D, Møller JV, Nissen P, J Struct Biol 2010 171 3 353 360 10.1016/j.jsb.2010.03.014 20347991
5. Drug binding to human alpha-1-acid glycoprotein in health and disease. Kremer JM, Wilting J, Janssen LH, Pharmacol Rev 1988 40 1 1 47 3064105
6. Age-related changes in protein binding of drugs: implications for therapy. Grandison MK, Boudinot FD, Clin Pharmacokinet 2000 38 3 271 290 10.2165/00003088-200038030-00005 10749520
7. The extraordinary ligand binding properties of human serum albumin. Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, Ascenzi P, IUBMB Life 2005 57 12 787 796 10.1080/15216540500404093 16393781
8. Antimicrobial peptides of multicellular organisms. Zasloff M, Nature 2002 415 6870 389 395 10.1038/415389a 11807545
9. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Hancock REW, Sahl H-G, Nat Biotechnol 2006 24 12 1551 1557 10.1038/nbt1267 17160061
10. Peptide antibiotics and their role in innate immunity. Boman HG, Annu Rev Immunol 1995 13 61 92 10.1146/annurev.iy.13.040195.000425 7612236
11. Natures antibiotics: the potential of antimicrobial peptides as new drugs. Diamond G, Biologist 2001 48 5 209 212 11584134
12. Mode of action of membrane active antimicrobial peptides. Shai Y, Biopolymers 2002 66 4 236 248 10.1002/bip.10260 12491537
13. Action of antimicrobial peptides: two-state model. Huang HW, Biochemistry 2000 39 29 8347 8352 10.1021/bi000946l 10913240
14. Identification of the bactericidal domain of lactoferrin. Bellamy W, Takase M, Yamauchi K, Wakabayashi H, Kawase K, Tomita M, Biochim Biophys Acta 1992 1121 1-2 130 136 1599934
15. Construction and synthesis of lactoferricin derivatives with enhanced antibacterial activity. Rekdal Ø Andersen J, Vorland LH, Svendsen JS, J Pept Sci 1999 5 32 45 10.1002/(SICI)1099-1387(199901)5:1<32::AID-PSC172>3. 0.CO;2-9
16. The pharmacophore of short cationic antibacterial peptides. Strøm MB, Haug BE, Skar ML, Stensen W, Stiberg T, Svendsen JS, J Med Chem 2003 46 9 1567 1570 10.1021/jm0340039 12699374
17. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. Haug BE, Stensen W, Stiberg T, Svendsen JS, J Med Chem 2004 47 17 4159 4162 10.1021/jm049582b 15293987
18. Altered activity and physicochemical properties of short cationic antimicrobial peptides by incorporation of arginine analogues. Svenson J, Karstad R, Flaten GE, Brandsdal B-O, Brandl M, Svendsen JS, Mol Pharm 2009 6 3 996 1005 10.1021/mp900057k 19341291
19. Targeting the S1 and S3 subsite of trypsin with unnatural cationic amino acids generates antimicrobial peptides with potential for oral administration. Karstad R, Isaksen G, Wynendaele E, Guttormsen Y, De Spiegeleer B, Brandsdal B-O, Svendsen JS, Svenson J, J Med Chem 2012 55 14 6294 6305 10.1021/jm3002058 22720778
20. Unnatural amino acid side chains as S1, S1′, and S2′ probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation. Karstad R, Isaksen G, Brandsdal B-O, Svendsen JS, Svenson J, J Med Chem 2010 53 15 5558 5566 10.1021/jm1006337 20608742
21. Albumin binding of short cationic antimicrobial micropeptides and its influence on the in vitro bactericidal effect. Svenson J, Brandsdal B-O, Stensen W, Svendsen JS, J Med Chem 2007 50 14 3334 3339 10.1021/jm0703542 17569519
22. Investigating the antimicrobial peptide 'window of activity' using cationic lipopeptides with hydrocarbon and fluorinated tails. Findlay B, Zhanel GG, Schweizer F, Int J Antimicrob Agents 2012 40 1 36 42 10.1016/j.ijantimicag. 2012.03.013 22578748
23. Antimicrobial peptides with stability toward tryptic degradation. Svenson J, Stensen W, Brandsdal B-O, Haug BE, Monrad J, Svendsen JS, Biochemistry 2008 47 12 3777 3788 10.1021/bi7019904 18307313
24. Synthetic antimicrobial peptidomimetics with therapeutic potential. Haug BE, Stensen W, Kalaaji M, Rekdal Ø Svendsen JS, J Med Chem 2008 51 14 4306 4314 10.1021/jm701600a 18570363
25. Metabolic fate of lactoferricin-based antimicrobial peptides: effect of truncation and incorporation of amino acid analogs on the in vitro metabolic stability. Svenson J, Vergote V, Karstad R, Burvenich C, Svendsen JS, De Spiegeleer B, J Pharmacol Exp Ther 2010 332 3 1032 1039 10.1124/jpet.109.162826 19952307
26. The medicinal chemistry of short lactoferricin-based antibacterial peptides. Haug BE, Strøm MB, Svendsen JSM, Curr Med Chem 2007 14 1 1 18 10.2174/092986707779313435 17266565
27. A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption. Isaksson J, Brandsdal BO, Engqvist M, Flaten GE, Svendsen JSM, Stensen W, J Med Chem 2011 54 16 5786 5795 10.1021/jm200450h 21732630
28. Multivalent antimicrobial peptides from a reactive polymer scaffold. Liu Z, Deshazer H, Rice AJ, Chen K, Zhou C, Kallenbach NR, J Med Chem 2006 49 12 3436 3439 10.1021/jm0601452 16759083
29. Length effects in antimicrobial peptides of the (RW)n series. Liu Z, Brady A, Young A, Rasimick B, Chen K, Zhou C, Kallenbach NR, Antimicrob Agents Chemother 2007 51 2 597 603 10.1128/AAC.00828-06 17145799
30. Tuning the membrane selectivity of antimicrobial peptides by using multivalent design. Liu Z, Young AW, Hu P, Rice AJ, Zhou C, Zhang Y, Kallenbach NR, ChemBioChem 2007 8 17 2063 2065 10.1002/cbic.200700502 17924379
31. Chiral separation mechanisms in protein-based HPLC columns. 1. Thermodynamic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Loun B, Hage DS, Anal Chem 1994 66 21 3814 3822 10.1021/ac00093a043 7802261
32. Chiral separation mechanisms in protein-based HPLC columns. 2. Kinetic studies of (R)- and (S)-warfarin binding to immobilized human serum albumin. Loun B, Hage DS, Anal Chem 1996 68 7 1218 1225 10.1021/ac950827p 8651495
33. Interaction of cucurbitacins with human serum albumin: thermodynamic characteristics and influence on the binding of site specific ligands. Abou-Khalil R, Jraij A, Magdalou J, Ouaini N, Tome D, Greige-Gerges H, J Photochem Photobiol B Biol 2009 95 3 189 195 10.1016/j.jphotobiol.2009.03.005
34. The characterization of two specific drug binding sites on human serum albumin. Sudlow G, Birkett DJ, Wade DN, Mol Pharmacol 1975 11 6 824 832 1207674
35. Binding sites of fluorescent probes on human serum albumin. Muller N, Lapicque F, Drelon E, Netter P, J Pharm Pharmacol 1994 46 4 300 304 10.1111/j.2042-7158.1994.tb03798.x 7519671
36. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. Dalvit C, Fogliatto G, Stewart A, Veronesi M, Stockman B, J Biomol NMR 2001 21 4 349 359 10.1023/A:1013302231549 11824754
37. Epitope mapping and competitive binding of HSA drug site II ligands by NMR diffusion measurements. Lucas LH, Price KE, Larive CK, J Am Chem Soc 2004 126 43 14258 14266 10.1021/ja0479538 15506793
38. Structural basis of the drug-binding specificity of human serum albumin. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S, J Mol Biol 2005 353 1 38 52 10.1016/j.jmb.2005.07.075 16169013
39. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Curry S, Drug Metab Pharmacokinet 2009 24 4 342 357 10.2133/dmpk.24.342 19745561
40. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Curry S, Mandelkow H, Brick P, Franks N, Nat Struct Biol 1998 5 9 827 835 10.1038/1869 9731778
41. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. Bhattacharya AA, Grüne T, Curry S, J Mol Biol 2000 303 5 721 732 10.1006/jmbi.2000.4158 11061971
42. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. Petitpas I, Grüne T, Bhattacharya AA, Curry S, J Mol Biol 2001 314 5 955 960 10.1006/jmbi.2000.5208 11743713
43. Susceptibility testing of antimicrobials in liquid media. Amsterdam D, Antibiotics in Laboratory Medicine Baltimore, MD: Williams and Wilkins, Lorian V, 4 1996 75 78
44. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water*. Dalvit C, Pevarello P, Tatò M, Veronesi M, Vulpetti A, Sundström M, J Biomol NMR 2000 18 1 65 68 10.1023/A:1008354229396 11061229
45. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. Mayer M, Meyer B, J Am Chem Soc 2001 123 25 6108 6117 10.1021/ja0100120 11414845
46. The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping. Sánchez-Pedregal VM, Reese M, Meiler J, Blommers MJJ, Griesinger C, Carlomagno T, Angew Chem Int Ed Engl 2005 44 27 4172 4175 10.1002/anie.200500503 15929149
47. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. Bhattacharya AA, Curry S, Franks NP, J Biol Chem 2000 275 49 38731 38738 10940303
48. Schrödinger LLC, New York 2012